SKU(재고 관리 코드):E4736Hu
Human Multidrug resistance protein 1,ABCB1 ELISA kit
Human Multidrug resistance protein 1,ABCB1 ELISA kit
Contact us for 48 wells and bulk quote
Introducing the Human Multidrug Resistance Protein 1, ABCB1 ELISA Kit, a highly reliable and accurate diagnostic tool meticulously designed for the detection and quantification of ABCB1 protein in human samples. This cutting-edge kit is specifically tailored to measure the expression levels of ABCB1, a pivotal protein that plays a crucial role in the development of multidrug resistance in cancer cells.
The ABCB1 ELISA Kit employs a state-of-the-art sandwich enzyme-linked immunosorbent assay technique, ensuring unparalleled sensitivity and specificity of the results. This innovative approach guarantees precise and dependable measurements, enabling researchers and clinicians to obtain accurate data for their cancer research and drug development endeavors.
Notably, the ABCB1 ELISA Kit is remarkably user-friendly, allowing for effortless utilization in laboratory settings. Its streamlined design and straightforward instructions facilitate a seamless workflow, saving valuable time and effort. Furthermore, this exceptional kit provides rapid results, enabling prompt analysis and decision-making.
The Human Multidrug Resistance Protein 1, ABCB1 ELISA Kit is an indispensable asset for any laboratory seeking to accurately measure ABCB1 protein expression levels in human samples. Its reliability, accuracy, and efficiency make it an ideal tool for researchers and clinicians involved in cancer research and drug development. With this kit, laboratories can confidently advance their understanding of multidrug resistance mechanisms and contribute to the development of effective therapeutic strategies.
Invest in the Human Multidrug Resistance Protein 1, ABCB1 ELISA Kit today and elevate your laboratory's capabilities in accurately measuring ABCB1 protein expression levels in human samples. Experience the precision and reliability that this invaluable tool brings to cancer research and drug development.